Abstract
It has been observed that the overproduction of Nitric Oxide (NO) causes disfunction of several organs and affects lactate level. Hence, attempts have been made to design and develop potent inhibitors for Nitric Oxide Synthases (NOSs), the enzymes which are responsible for its production. NOSs exist mainly in three different isoforms: neuronal, inducible, and endothelial, designated as nNOS, iNOS, and eNOS, respectively. For design and development of potent NOS inhibitors against all the 3 isoforms several Quantitative Structure-Activity Relationship (QSAR) studies were made. This article compiles comprehensively all such studies and discusses critically their outcome. For the inhibitors of all isoforms, some pharmacophore models have been developed in which commonly at least one H-bond donor, one H-bond acceptor, one hydrophobic group, and in some positively charged moieties have been found to be essential. Consistent to these pharmacophores, 2D and 3D QSAR studies have pointed out that all NOS inhibitors undergo H-bond, hydrophobic, electronic and steric interactions with the receptors.
Keywords: Nitric oxide synthase inhibitors, quantitative structure-activity relationships.
Current Enzyme Inhibition
Title:Quantitative Structure-Activity Relationship Studies on Nitric Oxide Synthase Inhibitors
Volume: 12 Issue: 1
Author(s): Satya P. Gupta, Harish Kumar and Basheerulla Shaik
Affiliation:
Keywords: Nitric oxide synthase inhibitors, quantitative structure-activity relationships.
Abstract: It has been observed that the overproduction of Nitric Oxide (NO) causes disfunction of several organs and affects lactate level. Hence, attempts have been made to design and develop potent inhibitors for Nitric Oxide Synthases (NOSs), the enzymes which are responsible for its production. NOSs exist mainly in three different isoforms: neuronal, inducible, and endothelial, designated as nNOS, iNOS, and eNOS, respectively. For design and development of potent NOS inhibitors against all the 3 isoforms several Quantitative Structure-Activity Relationship (QSAR) studies were made. This article compiles comprehensively all such studies and discusses critically their outcome. For the inhibitors of all isoforms, some pharmacophore models have been developed in which commonly at least one H-bond donor, one H-bond acceptor, one hydrophobic group, and in some positively charged moieties have been found to be essential. Consistent to these pharmacophores, 2D and 3D QSAR studies have pointed out that all NOS inhibitors undergo H-bond, hydrophobic, electronic and steric interactions with the receptors.
Export Options
About this article
Cite this article as:
P. Gupta Satya, Kumar Harish and Shaik Basheerulla, Quantitative Structure-Activity Relationship Studies on Nitric Oxide Synthase Inhibitors, Current Enzyme Inhibition 2016; 12 (1) . https://dx.doi.org/10.2174/1573408012666151126185958
DOI https://dx.doi.org/10.2174/1573408012666151126185958 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions
Current Drug Targets Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review
Current Drug Targets CIITA and the MHCII Enhanceosome in the Regulation of MHCII Expression
Current Genomics FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets Lentiviral Transgenesis - A Versatile Tool for Basic Research and Gene Therapy
Current Gene Therapy Antimicrobial Peptides Present in Mammalian Skin and Gut are Multifunctional Defence Molecules
Current Pharmaceutical Design Steroid Regulation of Drug-Metabolizing Cytochromes P450
Current Drug Metabolism Unravelling the Power of Omics for the Infertile Aging Male
Current Pharmaceutical Design Current Concepts in Reprogramming Somatic Cells to Pluripotent State
Current Stem Cell Research & Therapy ERK Signaling Pathway Regulates Embryonic Survival and Eye Development in Goldfish, Carassius auratus
Current Molecular Medicine Zinc-Permeable Ion Channels: Effects on Intracellular Zinc Dynamics and Potential Physiological/Pathophysiological Significance
Current Medicinal Chemistry Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
Current Pharmaceutical Design Activin Receptor-Like Kinases: Structure, Function and Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Tumor-Specific Delivery of Histidine-Rich Glycoprotein Suppresses Tumor Growth and Metastasis by Anti-angiogenesis and Vessel Normalization
Current Gene Therapy Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets
Current Drug Targets The Importance of TLR3 Expression and Hormonal Regulation of TLR3- Induced Immune Responses in the Human Endometrium
Current Immunology Reviews (Discontinued) Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Urinary Tract Tumors, Biology and Risk for Artificial Sweeteners Use with Particular Emphasis on some South American Countries
Current Nutrition & Food Science PPARγ and Early Human Placental Development
Current Medicinal Chemistry Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry